Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.
Ogawa T, Liggett TE, Melnikov AA, Monitto CL, Kusuke D, Shiga K, Kobayashi T, Horii A, Chatterjee A, Levenson VV, Koch WM, Sidransky D, Chang X.
Ogawa T, et al. Among authors: kusuke d.
Cell Cycle. 2012 Apr 15;11(8):1656-63. doi: 10.4161/cc.20120. Epub 2012 Apr 15.
Cell Cycle. 2012.
PMID: 22487682
Free PMC article.